Here, we found that treatment of glioma cells with axitinib triggers the DDR, evidenced by increased levels of phosphorylated H2AX and Ser345-Chk1, leading to cell cycle arrest at G2/M phase and accumulation of polyploid glioma cells undergoing mitotic catastrophe. Here, CHEK1 is linked to central nervous system cancer.